Literature DB >> 1657629

Stress and putative endogenous ligands for benzodiazepine receptors: the importance of characteristics of the aversive situation and of differential emotionality in experimental animals.

A Fernández-Teruel1, R M Escorihuela, A Tobeña, P Driscoll.   

Abstract

The relationships between anxiety/stress, possible endogenous ligands for benzodiazepine receptors and the behavioral modification by drugs are discussed in this short review, including the specific characteristics of elements involved in those interactions, e.g. ones concerning the aversiveness of the stressful situation and the nature of the organism under investigation. These are important factors when considering aversive tasks, insofar as they may involve stressful conditions which differ in intensity and in the degree of control afforded the subject. These characteristics may well lead to differing functional effects on GABA-gated chloride channels or, in other words, to an incongruous balance between endogenous benzodiazepine receptor agonist and inverse agonist activity. This is not surprising, as it is well known that different forms of stressors often actually produce divergent behavioral, physiological and biochemical effects. This review also illustrates the necessity of taking into account the variable effects of stressors and/or drugs on animals differing in reactivity or emotionality, even in the case of 'non-selected' stocks. The implication is made that, by genetic and/or environmental manipulation of the emotional state of the animals used, it will be possible to obtain more clearly definable results in neuropharmacological and psychopharmacological studies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657629     DOI: 10.1007/bf01923340

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  44 in total

Review 1.  A game with shifting mirrors.

Authors:  I Izquierdo
Journal:  Trends Pharmacol Sci       Date:  1989-12       Impact factor: 14.819

2.  Propranolol and chlordiazepoxide on experimentally induced conflict and shuttle box performance in rodents.

Authors:  R C Robichaud; K L Sledge; M A Hefner; M E Goldberg
Journal:  Psychopharmacologia       Date:  1973

3.  Differential hormonal and physiological responses to stress in Roman high- and low-avoidance rats.

Authors:  C Gentsch; M Lichtsteiner; P Driscoll; H Feer
Journal:  Physiol Behav       Date:  1982-02

4.  Inhibition by diazepam of the effect of additional training and of extinction on the retention of shuttle avoidance behavior in rats.

Authors:  M E Pereira; R Rosat; C H Huang; M G Godoy; I Izquierdo
Journal:  Behav Neurosci       Date:  1989-02       Impact factor: 1.912

5.  Effects of chlordiazepoxide and imipramine on maze patrolling within two different maze configurations by psychogenetically selected lines of rats.

Authors:  J R Martin; R Oettinger; P Driscoll; R Buzzi; K Bättig
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  Stock differences in the susceptibility of rats to learned helplessness training.

Authors:  S Wieland; J L Boren; P F Consroe; A Martin
Journal:  Life Sci       Date:  1986-09-08       Impact factor: 5.037

7.  Behavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex.

Authors:  L Rägo; R A Kiivet; J Harro; M Pŏld
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

8.  Rapid changes in GABA binding induced by stress in different areas of the rat brain.

Authors:  G Biggio; M G Corda; A Concas; G Demontis; Z Rossetti; G L Gessa
Journal:  Brain Res       Date:  1981-12-21       Impact factor: 3.252

9.  MR/Har and MNRA/Har Maudsley rat strains: differential response to chlordiazepoxide in a conflict task.

Authors:  R L Commissaris; T C McCloskey; G M Harrington; H J Altman
Journal:  Pharmacol Biochem Behav       Date:  1989-03       Impact factor: 3.533

10.  A theory of benzodiazepine dependence that can explain whether flumazenil will enhance or reverse the phenomena.

Authors:  S E File; P K Hitchcott
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

View more
  6 in total

1.  Infantile stimulation and the role of the benzodiazepine receptor system in adult acquisition of two-way avoidance behavior.

Authors:  R M Escorihuela; A Fernández-Teruel; F J Núñez; A Zapata; A Tobeña
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Ovarian steroids modify the behavioral and neurochemical responses of the central benzodiazepine receptor.

Authors:  D Bitran; J A Dowd
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

3.  Effects of prenatal diazepam on two-way avoidance behavior, swimming navigation and brain levels of benzodiazepine-like molecules in male Roman high- and low-avoidance rats.

Authors:  P Driscoll; P Ferré; A Fernández-Teruel; M Levi de Stein; C Wolfman; J Medina; A Tobeña; R M Escorihuela
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

4.  Differential effects of early stimulation and/or perinatal flumazenil treatment in young Roman low- and high-avoidance rats.

Authors:  A Fernández-Teruel; R M Escorihuela; P Driscoll; A Tobeña; K Bättig
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Similar effects of ethanol and flumazenil on acquisition of a shuttle-box avoidance response during withdrawal from chronic ethanol treatment.

Authors:  H E Criswell; G R Breese
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

6.  Neonatal handling decreases unconditioned anxiety, conditioned fear, and improves two-way avoidance acquisition: a study with the inbred Roman high (RHA-I)- and low-avoidance (RLA-I) rats of both sexes.

Authors:  Cristóbal Río-Ȧlamos; Ignasi Oliveras; Toni Cañete; Gloria Blázquez; Esther Martínez-Membrives; Adolf Tobeña; Alberto Fernández-Teruel
Journal:  Front Behav Neurosci       Date:  2015-07-10       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.